Robbiani D F, Finch R A, Jäger D, Muller W A, Sartorelli A C, Randolph G J
Department of Pathology and Immunology Program Weill Medical College and Graduate School of Medical Sciences of Cornell University, New York, NY 10029, USA.
Cell. 2000 Nov 22;103(5):757-68. doi: 10.1016/s0092-8674(00)00179-3.
Adaptive immune responses begin after antigen-bearing dendritic cells (DCs) traffic from peripheral tissues to lymph nodes. Here, we show that DC migration from skin to lymph nodes utilizes the leukotriene C(4) (LTC(4)) transporter multidrug resistance-associated protein 1 (MRP1). DC mobilization from the epidermis and trafficking into lymphatic vessels was greatly reduced in MRP1(-/-) mice, but migration was restored by exogenous cysteinyl leukotrienes LTC(4) or LTD(4). In vitro, these cysteinyl leukotrienes promoted optimal chemotaxis to the chemokine CCL19, but not to other related chemokines. Antagonism of CCL19 in vivo prevented DC migration out of the epidermis. Thus, MRP-1 regulates DC migration to lymph nodes, apparently by transporting LTC(4), which in turn promotes chemotaxis to CCL19 and mobilization of DCs from the epidermis.
适应性免疫反应始于携带抗原的树突状细胞(DCs)从外周组织迁移至淋巴结之后。在此,我们表明,DC从皮肤向淋巴结的迁移利用了白三烯C4(LTC4)转运体多药耐药相关蛋白1(MRP1)。在MRP1基因敲除小鼠中,DC从表皮的动员以及向淋巴管的迁移显著减少,但外源性半胱氨酰白三烯LTC4或LTD4可恢复其迁移。在体外,这些半胱氨酰白三烯促进了对趋化因子CCL19的最佳趋化作用,但对其他相关趋化因子则无此作用。体内CCL19的拮抗作用可阻止DC从表皮迁出。因此,MRP-1显然通过转运LTC4来调节DC向淋巴结的迁移,而LTC4反过来又促进对CCL19的趋化作用以及DC从表皮的动员。